Cancer cells that hijack NRF2 activity are equipped with a reinforced cytoprotective system through the induction of antioxidant and drug detoxification pathways, thereby rendering them resistant to oxidative stress and chemo/radio-therapy [[10], [11], [12]]. The gene discussed is NFE2L2; the disease is cancer.